Criteria of Rebulla et al for Administering Prophylactic Platelet Transfusions in a Patient with Acute Myeloid Leukemia


Rebulla et al listed criteria for when to administer platelet products prophylactically in a patient being treated for acute myeloid leukemia (AML). These criteria can help reduce the use of platelet products in these patients. The authors are from the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.

To read more or access our algorithms and calculators, please log in or register.


medal descover
medal iphone